158 related articles for article (PubMed ID: 2142409)
1. Prostaglandin E2 inhibits in vitro and in vivo lymphocyte responses in allogeneic transplantation.
Stone CD; Rosengard BR; Boorstein SM; Robbins RC; Hennein HA; Clark RE
Ann Thorac Surg; 1990 Jun; 49(6):927-30; discussion 931. PubMed ID: 2142409
[TBL] [Abstract][Full Text] [Related]
2. Portal vein administration of donor cells promotes peripheral allospecific hyporesponsiveness and graft tolerance.
Yu S; Nakafusa Y; Flye MW
Surgery; 1994 Aug; 116(2):229-34; discussion 234-5. PubMed ID: 8047989
[TBL] [Abstract][Full Text] [Related]
3. Pretreatment of donor stimulator cells by 16,16 dimethyl prostaglandin E2 influences the recipient immune response.
Chung SW; Gould B; Zhang R; Hu Y; Levy GA; Gorczynski RM
Surgery; 1998 Feb; 123(2):171-80. PubMed ID: 9481403
[TBL] [Abstract][Full Text] [Related]
4. Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts.
Gammie JS; Li S; Zeevi A; Demetris AJ; Ildstad ST; Pham SM
Circulation; 1998 Nov; 98(19 Suppl):II163-8; discussion II168-9. PubMed ID: 9852899
[TBL] [Abstract][Full Text] [Related]
5. Cellular mechanisms: induction of heart allograft survival in rats by 15-deoxyspergualin.
Jiang H; Takahara S; Kyo M; Takano Y; Kameoka H; Kokado Y; Ishibashi M; Okuyama A; Sonoda T
Transpl Int; 1992; 5 Suppl 1():S497-500. PubMed ID: 14621858
[TBL] [Abstract][Full Text] [Related]
6. Suppressor cells and intrathymic inoculation of donor alloantigens in cardiac transplantation.
Shen Z; Mohiuddin M; DiSesa VJ
Ann Thorac Surg; 1995 Dec; 60(6):1683-5. PubMed ID: 8787463
[TBL] [Abstract][Full Text] [Related]
7. 15AU81, a prostacyclin analog, enhances donor-specific hepatocytes to prolong the survival of rat heart but not small bowel allografts.
Boyle MJ; Dumble LJ
Cell Transplant; 1999; 8(5):543-8. PubMed ID: 10580348
[TBL] [Abstract][Full Text] [Related]
8. Long-term acceptance of composite tissue allografts through mixed chimerism and CD28 blockade.
Foster RD; Pham S; Li S; Aitouche A
Transplantation; 2003 Sep; 76(6):988-94. PubMed ID: 14508367
[TBL] [Abstract][Full Text] [Related]
9. CTLA4-Ig-based conditioning regimen to induce tolerance to cardiac allografts.
Li S; Salgar SK; Thanikachalam M; Murdock AD; Gammie JS; Demetris AJ; Zeevi A; Pham SM
J Surg Res; 2006 Dec; 136(2):238-46. PubMed ID: 17046021
[TBL] [Abstract][Full Text] [Related]
10. Intragraft delivery of 16, 16-dimethyl PGE2 induces donor-specific tolerance in rat cardiac allograft recipients.
Kamei T; Callery MP; Flye MW
Transplantation; 1991 Jan; 51(1):242-6. PubMed ID: 1987694
[TBL] [Abstract][Full Text] [Related]
11. Possible mechanism in rat with surviving heart allograft after short course of 15-deoxyspergualin treatment.
Jiang H; Takahara S; Kyo M; Takano Y; Kokado Y; Ishibashi M; Sonoda T
J Clin Lab Immunol; 1990 Jul; 32(3):131-6. PubMed ID: 1966949
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous administration of a low-dose mixture of donor bone marrow cells and splenocytes plus adenovirus containing the CTLA4Ig gene result in stable mixed chimerism and long-term survival of cardiac allograft in rats.
Jin Y; Zhang Q; Hao J; Gao X; Guo Y; Xie S
Immunology; 2003 Oct; 110(2):275-86. PubMed ID: 14511242
[TBL] [Abstract][Full Text] [Related]
13. Prolongation of rat heart allografts by donor-specific blood transfusion treated with ultraviolet irradiation.
Oluwole SF; Iga C; Lau H; Hardy MA
J Heart Transplant; 1985; 4(4):385-9. PubMed ID: 2956395
[TBL] [Abstract][Full Text] [Related]
14. Variable allograft responses to pretreatment with donor splenocytes treated with mitomycin C in the rat.
Yamaguchi Y; Harland R; Wyble C; Mori K; Bollinger RR
Transplantation; 1989 Feb; 47(2):360-3. PubMed ID: 2493180
[TBL] [Abstract][Full Text] [Related]
15. Production of antiidiotypic antibodies in the rat: in vitro characterization of specificity and correlation with in vivo specific suppression of cardiac allograft immune reaction across major histocompatibility complex.
Wasfie T; Reed E; Suciu-Foca N; Hardy MA
Surgery; 1990 Aug; 108(2):431-40; discussion 440-1. PubMed ID: 2143319
[TBL] [Abstract][Full Text] [Related]
16. Regulatory T cells maintain peripheral tolerance to islet allografts induced by intrathymic injection of MHC class I allopeptides.
Saborio DV; Chowdhury NC; Jin MX; Chandraker A; Sayegh MH; Oluwole SF
Cell Transplant; 1999; 8(4):375-81. PubMed ID: 10478717
[TBL] [Abstract][Full Text] [Related]
17. Composite tissue allotransplantation in chimeric hosts part II. A clinically relevant protocol to induce tolerance in a rat model.
Prabhune KA; Gorantla VS; Perez-Abadia G; Francois CG; Vossen M; Laurentin-Perez LA; Breidenbach WC; Wang GG; Anderson GL; Pidwell DJ; Barker JH; Maldonado C
Transplantation; 2003 Dec; 76(11):1548-55. PubMed ID: 14702522
[TBL] [Abstract][Full Text] [Related]
18. Induction of donor-specific hyporesponsiveness and prolongation of cardiac allograft survival by jejunal administration of donor splenocytes.
Ishido N; Matsuoka J; Matsuno T; Nakagawa K; Tanaka N
Transplantation; 1999 Nov; 68(9):1377-82. PubMed ID: 10573079
[TBL] [Abstract][Full Text] [Related]
19. Immature rat myeloid dendritic cells generated in low-dose granulocyte macrophage-colony stimulating factor prolong donor-specific rat cardiac allograft survival.
DePaz HA; Oluwole OO; Adeyeri AO; Witkowski P; Jin MX; Hardy MA; Oluwole SF
Transplantation; 2003 Feb; 75(4):521-8. PubMed ID: 12605121
[TBL] [Abstract][Full Text] [Related]
20. FK 506 and deoxyspergualin: additive immunosuppressive effect on rat cardiac allograft rejection in vivo and mitogen-stimulated human lymphocyte responses in vitro.
Jiang H; Takahara S; Li D; Namiki M; Ishibashi M; Okuyama A; Sonoda T
Transplant Proc; 1994 Aug; 26(4):2313-6. PubMed ID: 7520631
[No Abstract] [Full Text] [Related]
[Next] [New Search]
